An antagonist of the α3β4 nicotinic acetylcholine receptor subtype (IC50 = 10.2 μM); selectively binds the α3β4 subtype, compared to the α4β2 and α7 subtypes (Ki values of 0.508, >100, and >100 μM, respectively).